Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01111773 · ClinicalTrials.gov registry record · Phase 2
Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy
A Phase 2 study, sponsored by ZARS Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT01111773 is a Phase 2 study that has completed, run by ZARS Pharma. The registered enrollment target is 13 participants.
The verdict
NCT01111773, a Phase 2 study, has completed, sponsored by ZARS Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg and tetracaine 70 mg topical patch for the treatment of pain associated with patellar tendinopathy.
Interventions
- DRUG Heated Lidocaine and Tetracaine Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01111773
The ClinicalTrials.gov registry entry for NCT01111773 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZARS Pharma, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Heated Lidocaine and Tetracaine Patch is the first listed.
NCT01111773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01111773 about?
NCT01111773 is a clinical study titled "Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy". The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg and tetracaine 70 mg topical patch for the treatment of pain associated with patellar tendinopathy.
What is the current status of trial NCT01111773?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2010-06. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01111773?
The interventions under investigation include: Heated Lidocaine and Tetracaine Patch (DRUG).
Who is sponsoring clinical trial NCT01111773?
This trial is sponsored by ZARS Pharma, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.